Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.119 GBX | -5.93% | -12.50% | -45.66% |
Mar. 20 | Versarien raises GBP615,000 as eyes turnaround strategy | AN |
Mar. 20 | AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement | AN |
Sales 2021 | 6.57M 8.27M | Sales 2022 | 7.4M 9.32M | Capitalization | 26.97M 33.96M |
---|---|---|---|---|---|
Net income 2021 | -7M -8.81M | Net income 2022 | -5M -6.3M | EV / Sales 2021 | 8.44 x |
Net cash position 2021 | 2.02M 2.55M | Net Debt 2022 | 6.62M 8.34M | EV / Sales 2022 | 4.54 x |
P/E ratio 2021 |
-6.65
x | P/E ratio 2022 |
-5.01
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.88% |
1 day | -6.96% | ||
1 week | -13.46% | ||
Current month | +7.98% | ||
1 month | +7.00% | ||
3 months | -46.01% | ||
6 months | -90.39% | ||
Current year | -46.26% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Hodge
CEO | Chief Executive Officer | 37 | 18-07-15 |
Director of Finance/CFO | 64 | 13-07-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 64 | 13-07-02 | |
Director/Board Member | 66 | 16-02-02 | |
Stephen Hodge
CEO | Chief Executive Officer | 37 | 18-07-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.119 | -5.93% | 28 117 879 |
24-03-27 | 0.126 | +0.80% | 18,238,250 |
24-03-26 | 0.125 | +2.46% | 37,179,230 |
24-03-25 | 0.122 | -4.69% | 58,857,990 |
24-03-22 | 0.128 | -5.88% | 76,817,080 |
Delayed Quote London S.E., March 28, 2024 at 05:34 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.26% | 2.37M | |
+16.84% | 66.26B | |
-3.18% | 47.33B | |
+15.53% | 40.92B | |
+0.88% | 17.76B | |
+11.20% | 16.58B | |
-10.85% | 15.14B | |
+30.57% | 13.41B | |
-0.43% | 9.3B | |
-2.46% | 8.55B |